HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

James S Economou Selected Research

Paraneoplastic Syndromes (Paraneoplastic Syndrome)

8/2004Surveillance of the eye and vision in a clinical trial of MART1-transformed dendritic cells for metastatic melanoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


James S Economou Research Topics

Disease

28Melanoma (Melanoma, Malignant)
01/2019 - 11/2002
25Neoplasms (Cancer)
01/2019 - 02/2002
4Experimental Melanoma
06/2012 - 06/2005
3Liver Neoplasms (Liver Cancer)
04/2014 - 12/2003
2Diarrhea
10/2009 - 06/2007
2Hepatocellular Carcinoma (Hepatoma)
12/2007 - 05/2006
1Inflammation (Inflammations)
01/2018
1Basal Cell Carcinoma (Rodent Ulcer)
01/2012
1Hutchinson's Melanotic Freckle (Lentigo Maligna)
01/2012
1Actinic Keratosis
01/2012
1Condylomata Acuminata (Genital Wart)
01/2012
1B-Cell Lymphoma (Lymphoma, B Cell)
02/2011
1Hypophysitis
10/2009
1Combined Pituitary Hormone Deficiency
06/2007
1Autoimmune Hepatitis
06/2007
1Paraneoplastic Syndromes (Paraneoplastic Syndrome)
08/2004

Drug/Important Bio-Agent (IBA)

19AntigensIBA
04/2014 - 11/2002
12Peptides (Polypeptides)IBA
06/2018 - 02/2003
10HLA-A*02:01 antigenIBA
05/2013 - 03/2003
9T-Cell Antigen Receptors (T-Cell Receptor)IBA
06/2018 - 02/2011
8EpitopesIBA
01/2012 - 03/2003
6VaccinesIBA
05/2014 - 11/2002
5Neoplasm Antigens (Tumor Antigens)IBA
01/2018 - 06/2003
5tremelimumabIBA
06/2011 - 06/2007
4CytokinesIBA
01/2019 - 07/2008
4MART-1 AntigenIBA
01/2018 - 09/2003
4alpha-Fetoproteins (alpha-Fetoprotein)IBA
04/2014 - 12/2003
4Monoclonal AntibodiesIBA
06/2011 - 06/2007
3Histone Deacetylase InhibitorsIBA
04/2014 - 11/2009
3Proteins (Proteins, Gene)FDA Link
02/2011 - 06/2003
2RNA (Ribonucleic Acid)IBA
01/2019 - 06/2003
2DNA (Deoxyribonucleic Acid)IBA
04/2014 - 06/2003
2Proteasome Endopeptidase Complex (Proteasome)IBA
06/2012 - 04/2006
2Transcription Factors (Transcription Factor)IBA
11/2011 - 01/2009
2Monophenol Monooxygenase (Tyrosinase)IBA
11/2009 - 04/2008
2Dihydrotachysterol (AT 10)IBA
10/2009 - 05/2008
2Biomarkers (Surrogate Marker)IBA
01/2009 - 02/2003
1InterleukinsIBA
01/2019
1Protein Isoforms (Isoforms)IBA
01/2019
1drozitumabIBA
04/2014
1VemurafenibIBA
01/2014
1Complementary DNA (cDNA)IBA
05/2013
1Transforming Growth Factor beta (TGF-beta)IBA
06/2012
1InterferonsIBA
06/2012
1Toll-Like Receptor 7IBA
01/2012
1Imiquimod (Aldara)FDA LinkGeneric
01/2012
1OvalbuminIBA
11/2011
1LAQ824IBA
11/2009
1Histone Deacetylases (Histone Deacetylase)IBA
11/2009
1gp100 Melanoma AntigenIBA
11/2009
1EnzymesIBA
01/2009
1Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA
01/2009
1AntibodiesIBA
05/2008
1Melanoma-Specific AntigensIBA
04/2008
1CTLA-4 AntigenIBA
06/2007
1Proteasome InhibitorsIBA
04/2006
1Bortezomib (Velcade)FDA Link
04/2006
1Interleukin-10 (Interleukin 10)IBA
12/2004
1Interleukin-12 (IL 12)IBA
11/2002
1AutoantigensIBA
02/2002

Therapy/Procedure

13Immunotherapy
01/2018 - 02/2002
6Therapeutics
01/2018 - 08/2004
3Cell- and Tissue-Based Therapy (Cell Therapy)
05/2014 - 02/2011
3Injections
04/2014 - 08/2004
1Transplantation
05/2013
1Aftercare (After-Treatment)
01/2012
1Immunomodulation
01/2012
1Intradermal Injections
03/2003